PUBLIC COMPANY

$VERAVera Therapeutics, Inc.

Brisbane, CA, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 21pre_registration

Phase 2

traxivitug

Polyomavirus Infections

pre_registration

atacicept

IgA Nephropathy (Berger's Disease)

Tumor necrosis factor ligand superfamily member 13BTumor necrosis factor ligand superfamily member 13

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Vera Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

$VERA

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR

last refreshed 2m ago

Found something off?

Active trials

phase2Monthly Dosing of Atacicept in IgANactive not recruitingn=90
phase2Atacicept in Multiple Glomerular Diseasesrecruitingn=200
phase3Atacicept in Subjects With IgA Nephropathyactive not recruitingn=376
phase3Atacicept in Subjects With Active Lupus Nephritis (COMPASS)withdrawn
phase2A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ataciceptenrolling by invitationn=476
phase2A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipientscompletedn=30

Insider activity

source: SEC Form 4

90d open-market buys

$0

0 transactions

90d open-market sells

$1.01M

3 transactions

net (buys − sells)

−$1.01M

non-derivative only

open-market buys + sells

Apr 14, 26SELLFordyce Marshall· PRESIDENT AND CEO14,130 sh @ $43.66−$617K↗
Apr 14, 26SELLFordyce Marshall· PRESIDENT AND CEO7,921 sh @ $44.58−$353K↗
Apr 14, 26SELLFordyce Marshall· PRESIDENT AND CEO900 sh @ $45.51−$41K↗
Feb 23, 26SELLFordyce Marshall· PRESIDENT AND CEO16,925 sh @ $41.98−$711K↗
Feb 23, 26SELLGrant Sean· CHIEF FINANCIAL OFFICER4,949 sh @ $41.98−$208K↗
Feb 23, 26SELLYoung Joseph R· SVP, FINANCE, CHIEF ACCT OFFCR3,117 sh @ $41.98−$131K↗
Feb 23, 26SELLJOHNSON DAVID LEE· Chief Operating Officer2,579 sh @ $41.98−$108K↗
Feb 23, 26SELLTurner William D.· Chief Regulatory Officer2,187 sh @ $41.98−$92K↗
Feb 23, 26SELLBrenner Robert· Chief Medical Officer2,151 sh @ $41.98−$90K↗
Feb 23, 26SELLSkelton Laurence Matthew· Chief Commercial Officer1,582 sh @ $41.98−$66K↗

routine RSU / option mechanics (6)

Mar 23, 26grantWright-Mitchell Jane · Chief Legal Officer56,850 sh
Mar 23, 26grantWright-Mitchell Jane · Chief Legal Officer42,403 sh
Mar 13, 26option exerciseYoung Joseph R · SVP, FINANCE, CHIEF ACCT OFFCR10,000 sh
Mar 13, 26option exerciseYoung Joseph R · SVP, FINANCE, CHIEF ACCT OFFCR10,000 sh
Mar 5, 26grantHite Christopher · 24,937 sh

Feb 4, 26

grant

Grant Sean · CHIEF FINANCIAL OFFICER

25,000 sh